When was Advenza Global Limited incorporated?

Advenza Global Limited was incorporated on Feb 17, 2005. It is registered with the Registrar of Companies, Mumbai II, and its current company status is Active.

What is the Corporate Identification Number (CIN) of Advenza Global Limited?

Advenza Global Limited's Corporate Identification Number (CIN) is U24230MH2005PLC151389.

What is the registered address of Advenza Global Limited?

The registered address of Advenza Global Limited is Lodha Supremus II, Unit No.: 424, 4th F Road No. 22, Wagle Estate, Thane West, Maharashtra, India, 400604.

What is the latest employee count at Advenza Global Limited?

As of Apr 01, 2026, the latest employee count at Advenza Global Limited is 209.

Does Advenza Global Limited have any loans on it?

Advenza Global Limited has taken out 3 loans from the financial institutions ICICI BANK LIMITED and HDFC BANK LIMITED, with a total disclosed borrowing of over ₹5.75Cr. The largest loan was ₹3.75Cr from ICICI BANK LIMITED in Jan 2019.

Who are the authorized signatories of Advenza Global Limited?

As of Oct 2026, the authorized signatories of Advenza Global Limited include Chandrakumar Laxminarayan Rathi, Savita Chandrakumar Rathi and Radhika Ashish Pujara.

Has Advenza Global Limited raised funding?

Advanced Enzymes, the brand associated with Advenza Global Limited, has raised an undisclosed amount of funding over 2 funding rounds.

Who are the investors in Advenza Global Limited?

Advanced Enzymes, the brand associated with Advenza Global Limited, has total 3 investors, 3 are institutional investors including Nalanda Capital and 2 others.

Advenza Global Limited - 2026 Company Profile & Financials

Name: Advenza Global Limited
Brand: Advenza Global Limited
Price: 3.38 USD

Name	Short Description	Founded Year	Location	Current Stage
Advanced Enzymes	Manufacturer of enzymes for human nutrition, animal nutrition, food processing, and industrial applications	1989	India	Public
Advenza	Manufacturer of enzyme and custom probiotics solutions	2005	India	Unfunded

Main Activity Group Code	Description of Main Activity	Business Activity Code	Description of Business Activity	Turnover Percentage
C	Manufacturing	20	Manufacture of chemicals and chemical products	tbr

Filing Summary

Here is a summary of filing activity and document availability across financial years:

File Type	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Financial Statements
Annual Returns

Latest Financials, Share Allotment and Annual Report

The latest filed financial documents, annual reports, and share allotment filings are shown below:

Changes to Capital Structure

Buy Now

Recent Filings

Below are the most recent filings submitted by the company:

Document Name	Category	Filing Date
Form MSME	Other eForm Documents	Apr 24, 2026
Copy(s) of resolution(s) along with copy of explanatory statement under section 173	Other eForm Documents	Feb 16, 2026
Form MGT-14	Other eForm Documents	Feb 16, 2026
Optional attachment(s)- if any	Annual Returns and Balance Sheet eForms	Jan 30, 2026
List of share holders, debenture holders;	Annual Returns and Balance Sheet eForms	Jan 30, 2026
Form MGT-7	Annual Returns and Balance Sheet eForms	Jan 30, 2026
Form AOC-4(XBRL)	Annual Returns and Balance Sheet eForms	Jan 30, 2026
Form CSR-2	Annual Returns and Balance Sheet eForms	Jan 30, 2026
Photograph of the registered office of the Company showing external building and name prominently visible	Annual Returns and Balance Sheet eForms	Jan 30, 2026
Form MSME	Other eForm Documents	Oct 29, 2025

To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available

Advenza Global Limited generated between ₹50 Cr and ₹100 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of Advenza Global Limited has a compounded annual growth rate (CAGR) of -57% in the last 1 year.

Financial Statement Summary

Metrics	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Income Statement
Revenue	3948	4966	1746	4492	9608
Total Sales	8391	1867	7150	9718	7786
Total Expenses	9523	4626	5143	5785	5775
Operating Expenses	1727	4604	9494	5515	2655
Employee Expenses	8946	7850	3512	8017	5550
Marketing Expenses	3754	3025	1053	2944	6254
Operating Income (EBIT)	4715	9593	8766	3181	8900
Interest Expenses	8485	7001	4616	8674	8303
Expenses from other activities	8374	2397	1191	8710	8940
Information Technology Expenses	3188	5371	9059	6876	4716
EBITDA	1734	5930	3603	5556	1703
Taxes	2167	1114	5975	2802	1177
Net Profit	6972	9670	4032	3555	7360
Balance Sheet
Assets	7753	5510	1111	9849	7378
Cash Equivalent	3653	9138	6198	5971	9998
Accounts Receivables	1542	3993	2038	2191	1170
Inventory	3483	1326	2014	5444	2570
Liabilities	3927	1315	8185	9394	4008
Total Debt	3110	7809	5183	7358	4621
Accounts Payable	2241	5607	8819	5379	4246
Equities	1650	7136	3684	6536	8911
Cashflow Statement
Cash from Operating activities	2263	3616	6794	4348	2057
Cash from Investing activities	1440	1400	1951	8086	3556
Net cash from Financing activities	4008	5224	8792	8133	4483

To access detailed financial performance and data, Buy Financial Report FY 25 Available

Ratios

Metrics	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Profitability Ratios
EBITDA Margin	6203	4259	6432	9704	5658
EBIT Margin	3707	5998	9218	4744	2893
Net Profit Margin	8958	5567	2993	8190	1655
Return on Assets (ROA)	4745	6278	1220	5399	5542
Return on Equity (ROE)	4371	1276	8535	5586	9069
Return on Capital Employed	1716	8109	1253	3637	1587
Return on Invested Capital	4712	4921	2531	7545	3790
Efficiency Ratios
Asset Turnover	9534	4641	7888	1544	2573
Receivables Turnover	5320	5410	6835	9944	3832
Days Sales Outstanding	7593	4053	7905	9403	2780
Inventory Turnover	5165	1840	3413	3940	3505
Days Inventory Outstanding	3354	9835	3948	9854	5247
Payables Turnover	9891	2835	3075	6727	6386
Days Payables Outstanding	6359	6989	3368	4252	9773
Liquidity Ratios
Current Ratio	1704	2098	7685	3554	1127
Quick Ratio	2315	6249	8288	2876	3310
Cash Ratio	2904	3750	9053	9001	6952
Coverage Ratios
Cash Flow Coverage Ratio	5688	6802	6066	3863	1320
Debt Ratios
Debt-to-Equity Ratio	7821	8456	9698	9027	6274
Debt Ratio	9206	9316	5589	2074	6994
Net Debt	8730	2481	3824	8687	3629
Interest Coverage Ratio	8091	9411	5030	7963	9168
Debt Service Coverage Ratio	4192	8249	1066	9739	3442
Net Debt/EBITDA	1415	2727	5829	9509	4430
Growth Ratios
Revenue Growth Rate (CAGR)	1596	2843	1517	8818	8829
Earnings Growth Rate (CAGR)	8911	3091	8736	5385	1137

To access detailed financial performance and data, Buy Financial Report FY 25 Available

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Compounded Annual Growth Rate of Advenza Global Limited

Revenue CAGR	Growth
1 Year	-57%
3 Year	420
5 Year	464

EBITDA CAGR	Growth
1 Year	-98%
3 Year	818
5 Year	229

Disclaimer

There are 4 delayed MSME payments recorded for Advenza Global Limited during Oct 2025 - Mar 2026.

Here are the details of MSME payment delays for this period:

Supplier Name	Supplier PAN	Amount Due	Due since
Saroj Art Printers Private Limited	1643	5844	3868
V.N.Pharma	8494	1201	2191
Bharat Milling Industries	1396	8050	6331
RADHEKRISHNA DISTRIBUTORS	4268	9260	3914

To access detailed supplier-wise and period-wise MSME payment delay information,

Advenza Global Limited has taken 3 loans.

Here is a list of loans and charges on Advenza Global Limited:

As a Borrower

Loan/ Charge ID	Lender Name	Loan Amount	Status	Creation Date	Closure Date
100240011	ICICI BANK LIMITED	₹3.75Cr	noqcuxo	Jan 30, 2019	qojhpi{
10599909	HDFC BANK LIMITED	₹1Cr	nfcrumo	Oct 28, 2015	vfhlbqh
10604386	HDFC BANK LIMITED	₹1Cr	xjsamfg	Oct 15, 2015	toealts

To access detailed information on a company’s loans, borrowings, & registered charges,

Board of Directors of Advenza Global Limited

Here is the list of current board of directors of Advenza Global Limited:

Name	Designation	Status	Appointment Date	Duration
Piyush Chandrakumar Rathi	Managing Director	Current	Dec 01, 2020	5 Years 10 Months
Savita Chandrakumar Rathi	Director	Current	Feb 17, 2005	21 Years 7 Months
Chandrakumar Laxminarayan Rathi	Director	Current	Feb 17, 2005	21 Years 7 Months
Radhika Ashish Pujara	Director	Current	Sep 14, 2015	11 Years
Divya Piyush Rathi	Director	Current	Sep 14, 2015	11 Years
Ashish Mulchand Gala	Director	Current	Aug 20, 2025	1 Year 1 Month
Jayesh Narendra Sheth	Director	Current	Aug 20, 2025	1 Year 1 Month

To access detailed information on a company’s board members, directors, & authorized signatories,

Signatories of Advenza Global Limited

Here is the list of current signatories of Advenza Global Limited:

Name	Designation(s)	Status	Appointment Date	Duration
Chandrakumar Laxminarayan Rathi	Director	Current	Feb 17, 2005	21 Years 7 Months
Savita Chandrakumar Rathi	Director	Current	Feb 17, 2005	21 Years 7 Months
Radhika Ashish Pujara	Director	Current	Sep 14, 2015	11 Years
Divya Piyush Rathi	Director	Current	Sep 14, 2015	11 Years
Piyush Chandrakumar Rathi	Managing Director	Current	Dec 01, 2020	5 Years 10 Months
Bhavna Jain	Company Secretary	Current	Jul 07, 2025	1 Year 3 Months
Jayesh Narendra Sheth	Director	Current	Aug 20, 2025	1 Year 1 Month
Nikhil Jugalkishor Kalantri	CFO	Current	Aug 20, 2025	1 Year 1 Month
Ashish Mulchand Gala	Director	Current	Aug 20, 2025	1 Year 1 Month

To access detailed information on a company’s board members, directors, & authorized signatories,

Cross Directorships of Advenza Global Limited

Advenza Global Limited has directors who also hold positions in 3 other legal entities. All are listed below:

Legal Entity Name	% of Common Directors	Common Director(s)	Open Charge(s)	Active Legal Case(s)
Shirdi Sai Nutraceuticals Private Limited CIN: U15139MH2012PTC450211, India, Active	995	119	166	332
ATHARVA GREEN ECOTECH PRIVATE LIMITED CIN: U74110MH1993PTC073191, India, Converted to LLP	237	209	652	511
CHANDRAKANT RATHI INNOVATIONS & PROJECTS PRIVATE LIMITED CIN: U74110MH1994PTC081231, India, Amalgamated	897	539	266	209

To access detailed information on a company’s board members, directors, & authorized signatories,

Advanced Enzymes, the brand associated with Advenza Global Limited, has raised funding over 2 rounds. Its first funding round was on May 07, 2018. Its latest funding round was a Post IPO round on Sep 2020 for $*****. 1 investor participated in its latest round. Advanced Enzymes has 3 institutional investors.

Here is the list of recent funding rounds of Advanced Enzymes:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 2020	1832127	Post IPO	1164172	9262619	9728074	7218018
May 07, 2018	5826037	Conventional Debt	6828108	7777594	1207393	Avendus

Access detailed funding, investor, and valuation insights.

Advenza Global Limited has an employee count of 209 as on Apr 01, 2026.

Employee count trend for Advenza Global Limited

Date	Employee Count
Apr 26	209
Mar 26	360
Feb 26	700
Jan 26	142
Dec 25	507
Nov 25	156
Oct 25	833

There are two brands associated with Advenza Global Limited, namely Advanced Enzymes and Advenza. Here is the list of the Top 10 competitors of Advanced Enzymes ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Novozymes 2000, Bagsvaerd (Denmark), Acquired	Developer of biosolutions and enzymes for multiple industries and applications of biotechnology	$9.75M	DOE, CHV & 3 others	73/100
2nd	Advanced Enzymes 1989, Thane (India), Public	Manufacturer of enzymes for human nutrition, animal nutrition, food processing, and industrial applications	-	Nalanda Capital, Avendus & 1 others	62/100
3rd	Infinita Biotech 2015, Vadodara (India), Unfunded	Provider of enzymatic solutions for various industries	-	-	40/100
4th	Advenza 2005, Thane (India), Unfunded	Manufacturer of enzyme and custom probiotics solutions	-	-	39/100
5th	Amlan International 1941, Chicago (United States), Unfunded	Provider of mineral-based feed additives that support animal intestinal health	-	-	38/100
6th	Antozyme Biotech 2015, Vadodara (India), Unfunded	Enzymes manufacturing and formulation company	-	-	37/100
7th	Inter 1952, Toronto (Canada), Public	Provider of dolomite, clay products, and nutritional supplements for animal feed	-	-	36/100
8th	SynkroMax 2009, Chennai (India), Funding Raised	Manufacturer of tissue engineered products and enzymes for multiple industries	-	Connect Ventures, BIRAC	34/100
9th	Tex Biosciences 1979, Chennai (India), Funding Raised	Manufacturer of enzymes, probiotics, and specialty chemicals for various industries	-	BIRAC	32/100
10th	Fruzyme 2013, Tiruppur (India), Unfunded	Company specializing in the development and manufacturing of enzymes for various industries, including food, baking, animal feed, and pharmaceuticals	-	-	32/100

To view the full list of competitors of Advanced Enzymes and the other associated brands,

Media has covered brands linked with Advenza Global Limited for a total of 8 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.